Login or sign up
For business

Eisai emea

4.0ยท 12 reviews
Average ratingGreat
4.0/ 5

Based on 12 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Eisai emea

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Kristie Pappal
Reviews 1

I recently purchased medication from a reputable UK-based company. The entire process was smooth and hassle-free. The products were exactly as described and the delivery was prompt. I would highly recommend them to anyone in need of pharmaceutical products.

Mead Rust
Reviews 1

Eisai emea is a reputable company with a strong presence in the pharmaceutical industry. Their products are of excellent quality, and their customer service is exceptional. I have been using their products for several years and have never been disappointed. I highly recommend them to anyone in need of reliable pharmaceutical solutions.

Sandy Rust
Reviews 1

I recently used the services of a UK-based pharmaceutical company for the first time. I was impressed with the level of professionalism and efficiency. The staff was knowledgeable and helpful throughout the process. I will definitely be using their services again in the future.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Eisai emea

Our work at Eisai prioritises patients and their families through our focus to continually improve the benefits that health care can provide.

Eisai EMEA: A Company that Prioritizes Patients and Their Families

Eisai EMEA is a pharmaceutical company that has been in the industry for over 25 years. The company's mission is to prioritize patients and their families by continually improving the benefits that healthcare can provide. Eisai EMEA has a strong presence in Europe, the Middle East, Africa, and Russia.

The company's focus on patients is evident in its commitment to developing innovative medicines that address unmet medical needs. Eisai EMEA has a diverse portfolio of products that cover various therapeutic areas such as oncology, neurology, gastrointestinal disorders, and metabolic disorders.

One of Eisai EMEA's flagship products is Lenvima (lenvatinib), an oral kinase inhibitor used to treat thyroid cancer and renal cell carcinoma. Lenvima was approved by the European Medicines Agency (EMA) in 2015 and has since been approved for other indications such as hepatocellular carcinoma.

Another product from Eisai EMEA's portfolio is Fycompa (perampanel), an antiepileptic drug used to treat partial-onset seizures with or without secondary generalization. Fycompa was approved by the EMA in 2012 and has since been approved for other indications such as primary generalized tonic-clonic seizures.

Eisai EMEA also focuses on research and development (R&D) activities aimed at discovering new treatments for various diseases. The company invests heavily in R&D activities with over 20% of its revenue being allocated towards this area.

In addition to its commitment to patients, Eisai EMEA also prioritizes sustainability through its corporate social responsibility initiatives. The company aims to reduce its environmental impact through energy-efficient practices while also supporting local communities through various programs.

Eisai EMEA's commitment to patients, innovation, sustainability, and community makes it stand out among other pharmaceutical companies. The company's focus on patients and their families is evident in its diverse portfolio of products that address unmet medical needs. Eisai EMEA's commitment to sustainability and community also sets it apart from other companies in the industry.

In conclusion, Eisai EMEA is a pharmaceutical company that prioritizes patients and their families through its commitment to developing innovative medicines that address unmet medical needs. The company's focus on sustainability and community also makes it stand out among other companies in the industry. With its strong presence in Europe, the Middle East, Africa, and Russia, Eisai EMEA is poised to continue making a positive impact on healthcare for years to come.

Address
Mosquito Way
Categories
Pharmaceuticals